Limited value of 18F-FDG PET/CT and S-100B tumour marker in the detection of liver metastases from uveal melanoma compared to liver metastases from cutaneous melanoma

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 36, Issue 11, 2009, Pages 1774-1782

  Strobel, K ^a   Bode, B ^a   Dummer, R ^b   Veit Haibach, P ^a   Fischer, D R ^a   Imhof, L ^b   Goldinger, S ^b   Steinert, Hans C ^a   Von Schulthess, G K ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Cutaneous melanoma; Liver metastases; Uveal melanoma

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE TRANSPORTER 1; PROTEIN S 100; PROTEIN S100B; DIAGNOSTIC AGENT; NERVE GROWTH FACTOR; S 100 CALCIUM BINDING PROTEIN BETA SUBUNIT; S-100 CALCIUM-BINDING PROTEIN BETA SUBUNIT; TUMOR MARKER;

ADRENAL METASTASIS; ADULT; AGED; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; CANCER DIAGNOSIS; CANCER SURVIVAL; CELL GROWTH; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYTOLOGY; EPITHELIUM CELL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; MELANOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PERITONEUM METASTASIS; PROTEIN EXPRESSION; SOFT TISSUE METASTASIS; SPINDLE CELL; UVEA MELANOMA; BLOOD; COMPARATIVE STUDY; LIVER TUMOR; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; RETROSPECTIVE STUDY; SKIN TUMOR; UVEA TUMOR;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LIVER NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; NERVE GROWTH FACTORS; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RETROSPECTIVE STUDIES; S100 PROTEINS; SKIN NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL; UVEAL NEOPLASMS;

EID: 72149106179     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-009-1175-0     Document Type: Article

References (39)

1. MJ Dalrymple-Hay PD Rome C Kennedy M Fulham BC McCaughan 2002 Pulmonary metastatic melanoma-the survival benefit associated with positron emission tomography scanning Eur J Cardiothorac Surg 21 611 614 10.1016/S1010-7940(02) 00026-X 10.1016/S1010-7940(02)00026-X 1:STN:280:DC%2BD387pvFemug%3D%3D 11932155 discussion 614-615 (Pubitemid 34257944)
2. MJ Reinhardt AY Joe U Jaeger A Huber A Matthies J Bucerius, et al. 2006 Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N-and M-staging of malignant melanoma: experience with 250 consecutive patients J Clin Oncol 24 1178 1187 10.1200/JCO.2005.03.5634 10.1200/JCO.2005.03.5634 16505438 (Pubitemid 46638816)
3. K Strobel R Dummer DB Husarik M Pérez Lago TF Hany HC Steinert 2007 High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases Radiology 244 566 574 10.1148/radiol.2442061099 10.1148/radiol.2442061099 17641374 (Pubitemid 47080890)
4. K Strobel J Skalsky V Kalff K Baumann B Seifert H Joller-Jemelka, et al. 2007 Tumour assessment in advanced melanoma: value of FDG-PET/CT in patients with elevated serum S-100B Eur J Nucl Med Mol Imaging 34 1366 1375 10.1007/s00259-007-0403-8 10.1007/s00259-007-0403-8 17390135 (Pubitemid 47312588)
5. AD Singh A Topham 2003 Incidence of uveal melanoma in the United States: 1973-1997 Ophthalmology 110 956 961 10.1016/S0161-6420(03) 00078-2 10.1016/S0161-6420(03)00078-2 12750097 (Pubitemid 36560496)
6. G Virgili G Gatta L Ciccolallo R Capocaccia A Biggeri E Crocetti, et al. 2007 Incidence of uveal melanoma in Europe Ophthalmology 114 2309 2315 10.1016/j.ophtha.2007.01.032 10.1016/j.ophtha.2007.01.032 17498805 (Pubitemid 350181097)
7. DM Albert LM Ryan EC Borden 1996 Metastatic ocular and cutaneous melanoma: a comparison of patient characteristics and prognosis Arch Ophthalmol 114 107 108 1:STN:280:DyaK287jtlagsg%3D%3D 8540843
8. C Belmar-Lopez P Mancheno-Corvo MA Saornil P Baril G Vassaux M Quintanilla, et al. 2008 Uveal vs. cutaneous melanoma. Origins and causes of the differences Clin Transl Oncol 10 137 142 10.1007/s12094-008-0170-4 10.1007/s12094-008-0170-4 18321815
9. LG Baggetto J Gambrelle G Dayan S Labialle S Barakat M Michaud, et al. 2005 Major cytogenetic aberrations and typical multidrug resistance phenotype of uveal melanoma: current views and new therapeutic prospects Cancer Treat Rev 31 361 379 10.1016/j.ctrv.2005.05.001 10.1016/j.ctrv.2005.05.001 15994016 (Pubitemid 41430691)
10. B Damato 2004 Developments in the management of uveal melanoma Clin Experiment Ophthalmol 32 639 647 10.1111/j.1442-9071.2004.00917.x 10.1111/j.1442-9071.2004.00917.x 15575836 (Pubitemid 40074112)
11. EC Hsueh R Essner LJ Foshag X Ye HJ Wang DL Morton 2004 Prolonged survival after complete resection of metastases from intraocular melanoma Cancer 100 122 129 10.1002/cncr.11872 10.1002/cncr.11872 14692032 (Pubitemid 37553547)
12. AY Bedikian SS Legha G Mavligit CH Carrasco S Khorana C Plager, et al. 1995 Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors Cancer 76 1665 1670 10.1002/1097-0142(19951101) 76:9<1665::AID-CNCR2820760925>3.0. CO;2-J 10.1002/1097-0142(19951101)76:9<1665::AID-CNCR2820760925>3.0.CO;2-J 1:CAS:528:DyaK28XjtFCi 8635073
13. ED Feldman JF Pingpank HR Alexander Jr 2004 Regional treatment options for patients with ocular melanoma metastatic to the liver Ann Surg Oncol 11 290 297 10.1245/ASO.2004.07.004 10.1245/ASO.2004.07.004 14993024 (Pubitemid 40486769)
14. KV Sharma JE Gould JW Harbour GP Linette TK Pilgram PN Dayani, et al. 2008 Hepatic arterial chemoembolization for management of metastatic melanoma AJR Am J Roentgenol 190 99 104 10.2214/AJR.07.2675 10.2214/AJR.07.2675 18094299
15. T Vogl K Eichler S Zangos C Herzog R Hammerstingl J Balzer, et al. 2007 Preliminary experience with transarterial chemoembolization (TACE) in liver metastases of uveal malignant melanoma: local tumor control and survival J Cancer Res Clin Oncol 133 177 184 10.1007/s00432-006-0155-z 10.1007/s00432-006- 0155-z 1:CAS:528:DC%2BD2sXmt1Kksw%3D%3D 17021903 (Pubitemid 46144093)
16. KT Sato RJ Lewandowski MF Mulcahy B Atassi RK Ryu VL Gates, et al. 2008 Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres-safety, efficacy, and survival Radiology 247 507 515 10.1148/radiol.2472062029 10.1148/radiol.2472062029 18349311
17. HD Abraha LC Fuller AW Du Vivier EM Higgins RA Sherwood 1997 Serum S-100 protein: a potentially useful prognostic marker in cutaneous melanoma Br J Dermatol 137 381 385 10.1111/j.1365-2133.1997.tb03742.x 10.1111/j.1365-2133. 1997.tb03742.x 1:CAS:528:DyaK2sXmslyitL8%3D 9349333
18. R Andrés JI Mayordomo P Zaballos J Rodino D Isla P Escudero, et al. 2004 Prognostic value of serum S-100B in malignant melanoma Tumori 90 607 610 15762365
19. T Bánfalvi K Gilde M Boldizsár T Kremmer S Ottó 1999 Serum levels of S-100 protein and 5-S-cysteinyldopa as markers of melanoma progression Pathol Oncol Res 5 218 222 10.1053/paor.1999.0218 10.1053/paor.1999.0218 10491021 (Pubitemid 29510777)
20. J Domingo-Domènech R Molina T Castel C Montagut S Puig C Conill, et al. 2005 Serum protein s-100 predicts clinical outcome in patients with melanoma treated with adjuvant interferon-comparison with tyrosinase rt-PCR Oncology 68 341 349 10.1159/000086973 10.1159/000086973 16020961 (Pubitemid 41160962)
21. HB Guo B Stoffel-Wagner T Bierwirth J Mezger D Klingmüller 1995 Clinical significance of serum S100 in metastatic malignant melanoma Eur J Cancer 31A 1898 1902 10.1016/0959-8049(95) 00087-Y 10.1016/0959-8049(95)00087-Y 1:STN:280:DyaK287jvVWhtw%3D%3D 8541129
22. AP Hamberg CM Korse JM Bonfrer GC de Gast 2003 Serum S100B is suitable for prediction and monitoring of response to chemoimmunotherapy in metastatic malignant melanoma Melanoma Res 13 45 49 10.1097/00008390-200302000-00008 10.1097/00008390-200302000-00008 1:CAS:528:DC%2BD3sXptFOhtg%3D%3D 12569284 (Pubitemid 36269813)
23. V Barak S Frenkel I Kalickman AJ Maniotis R Folberg J Pe'er 2007 Serum markers to detect metastatic uveal melanoma Anticancer Res 27 1897 1900 1:CAS:528:DC%2BD2sXotVCru7c%3D 17649791
24. GS Missotten CM Korse C van Dehn TC Linders JE Keunen MJ Jager, et al. 2007 S-100B protein and melanoma inhibitory activity protein in uveal melanoma screening. A comparison with liver function tests Tumour Biol 28 63 69 10.1159/000099151 10.1159/000099151 1:CAS:528:DC%2BD2sXjsVyitbk%3D 17264538 (Pubitemid 46328593)
25. GS Missotten NE Tang CM Korse HM Hurks D de Wolff-Rouendaal JE Keunen, et al. 2003 Prognostic value of S-100-beta serum concentration in patients with uveal melanoma Arch Ophthalmol 121 1117 1119 10.1001/archopht.121.8.1117 10.1001/archopht.121.8.1117 1:CAS:528:DC%2BD3sXntVequrw%3D 12912688 (Pubitemid 36962164)
26. K Strobel R Dummer HC Steinert KB Conzett K Schad MP Lago, et al. 2008 Chemotherapy response assessment in stage IV melanoma patients-comparison of 18F-FDG-PET/CT, CT, brain MRI, and tumormarker S-100B Eur J Nucl Med Mol Imaging 35 1786 1795 10.1007/s00259-008-0806-1 10.1007/s00259-008-0806-1 18458901
27. K Strobel J Skalsky HC Steinert R Dummer TF Hany U Bhure, et al. 2007 S-100B and FDG-PET/CT in therapy response assessment of melanoma patients Dermatology 215 192 201 10.1159/000106575 10.1159/000106575 1:CAS:528: DC%2BD2sXpvF2rs78%3D 17823514 (Pubitemid 47378984)
28. M Kurli S Reddy LB Tena AC Pavlick PT Finger 2005 Whole body positron emission tomography/computed tomography staging of metastatic choroidal melanoma Am J Ophthalmol 140 193 199 15992753
29. PT Finger M Kurli S Reddy LB Tena AC Pavlick 2005 Whole body PET/CT for initial staging of choroidal melanoma Br J Ophthalmol 89 1270 1274 10.1136/bjo.2005.069823 10.1136/bjo.2005.069823 1:STN:280:DC%2BD2Mvps1OjtA%3D%3D 16170114 (Pubitemid 41638863)
30. C Hicks AJ Foss JL Hungerford 1998 Predictive power of screening tests for metastasis in uveal melanoma Eye 12 Pt 6 945 948 10325992
31. T Meir R Dror X Yu J Qian I Simon J Pe'er, et al. 2007 Molecular characteristics of liver metastases from uveal melanoma Invest Ophthalmol Vis Sci 48 4890 4896 10.1167/iovs.07-0215 10.1167/iovs.07-0215 17962435 (Pubitemid 351260893)
32. CL Shields 2008 The hunt for the secrets of uveal melanoma Clin Experiment Ophthalmol 36 277 280 10.1111/j.1442-9071.2008.01717.x 10.1111/j.1442-9071.2008.01717.x 18412599 (Pubitemid 351560278)
33. JK Chung YJ Lee C Kim SR Choi M Kim K Lee, et al. 1999 Mechanisms related to [18F]fluorodeoxyglucose uptake of human colon cancers transplanted in nude mice J Nucl Med 40 339 346 1:CAS:528:DyaK1MXivVGlsro%3D 10025844
34. LC Ong Y Jin IC Song S Yu K Zhang PK Chow 2008 2-[18F]-2-deoxy-D-glucose (FDG) uptake in human tumor cells is related to the expression of GLUT-1 and hexokinase II Acta Radiol 49 1145 1153 10.1080/02841850802482486 10.1080/02841850802482486 18979289
35. K Hamada Y Tomita Y Qiu B Zhang T Ueda A Myoui, et al. 2008 18F-FDG-PET of musculoskeletal tumors: a correlation with the expression of glucose transporter 1 and hexokinase II Ann Nucl Med 22 699 705 10.1007/s12149-008-0173- 9 10.1007/s12149-008-0173-9 18982473
36. T Higashi T Saga Y Nakamoto T Ishimori MH Mamede M Wada, et al. 2002 Relationship between retention index in dual-phase (18) F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer J Nucl Med 43 173 180 1:CAS:528:DC%2BD38XjvFWjtr0%3D 11850481
37. B Paudyal N Oriuchi P Paudyal T Higuchi T Nakajima K Endo 2008 Expression of glucose transporters and hexokinase II in cholangiocellular carcinoma compared using [18F]-2-fluro-2-deoxy-D-glucose positron emission tomography Cancer Sci 99 260 266 10.1111/j.1349-7006.2007.00683.x 10.1111/j.1349-7006.2007. 00683.x 1:CAS:528:DC%2BD1MXjs1ygtLY%3D 18271924 (Pubitemid 351228478)
38. RJ Downey T Akhurst M Gonen B Park V Rusch 2007 Fluorine-18 fluorodeoxyglucose positron emission tomographic maximal standardized uptake value predicts survival independent of clinical but not pathologic TNM staging of resected non-small cell lung cancer J Thorac Cardiovasc Surg 133 1419 1427 10.1016/j.jtcvs.2007.01.041 10.1016/j.jtcvs.2007.01.041 17532932 (Pubitemid 46802579)
39. T Maeda U Tateishi S Suzuki Y Arai EE Kim K Sugimura 2007 Magnetic resonance screening trial for hepatic metastasis in patients with locally controlled choroidal melanoma Jpn J Clin Oncol 37 282 286 10.1093/jjco/hym018 10.1093/jjco/hym018 17553818 (Pubitemid 47090680)